Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

3(50.0%)

Phase 2

2(33.3%)

N/A

1(16.7%)

6Total

Phase 4(3)

Phase 2(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05086679Not ApplicableUnknown

Compression Stockings for Treating Vasovagal Syncope Trial

Role: collaborator

NCT05097664Unknown

Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran

Role: collaborator

NCT01863641Phase 2Unknown

The Effect of Calcitriol on Progress and Activity of Lupus Nephritis

Role: lead

NCT01593774Phase 2Completed

Melatonin for Prevention of Metabolic Side Effects of Olanzapine

Role: lead

NCT01241110Phase 4Completed

To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment

Role: lead

NCT00707850Phase 4Completed

Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection

Role: collaborator

NCT00707772Phase 4Completed

Pegasys® Plus Ribavirin in Hemophilic Patients With Hepatitis C Virus Infection

Role: collaborator

All 7 trials loaded